clotrimazole has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grössinger, EM | 1 |
| Weiss, L | 1 |
| Zierler, S | 1 |
| Rebhandl, S | 1 |
| Krenn, PW | 1 |
| Hinterseer, E | 1 |
| Schmölzer, J | 1 |
| Asslaber, D | 1 |
| Hainzl, S | 1 |
| Neureiter, D | 1 |
| Egle, A | 1 |
| Piñón-Hofbauer, J | 1 |
| Hartmann, TN | 1 |
| Greil, R | 1 |
| Kerschbaum, HH | 1 |
1 other study available for clotrimazole and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.
Topics: Antigens, CD19; Cell Proliferation; Clotrimazole; Humans; Intermediate-Conductance Calcium-Activated | 2014 |